SCHEMBL29137409

SCHEMBL29137409

CC1(C)CCN(Cc2ccccc2)C(=O)C1(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
MEN1 O00255 1/20 0.58
ELANE P08246 3/20 0.49
DDB1 Q16531 1/20 0.47
CRBN Q96SW2 1/20 0.47
GAA P10253 1/20 0.45
HSD11B1 P28845 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
RIPK1 Q13546 1/20 0.44
POLB P06746 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CTSG P08311 1/20 0.43
PRTN3 P24158 1/20 0.43
KCNH2 Q12809 2/20 0.42
DRD3 P35462 1/20 0.42
MC4R P32245 1/20 0.42
OPRM1 P35372 2/20 0.41
SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24992399 0.83 KMT2A (0.61) KMT2AMEN1ELANEDDB1CRBN
SCHEMBL13201398 0.81 KMT2A (0.58) KMT2AMEN1ELANEDDB1CRBN
SCHEMBL16488087 0.79 MEN1 (0.56) KMT2AMEN1ELANEDDB1CRBN
SCHEMBL22147753 0.79 KMT2A (0.56) KMT2AMEN1ELANEDDB1CRBN
SCHEMBL6730533 0.79 KMT2A (0.56) KMT2AMEN1ELANEDDB1CRBN
SCHEMBL3194202 0.78 KMT2A (0.55) KMT2AMEN1ELANEDDB1CRBN
SCHEMBL22394885 0.77 KMT2A (0.61) KMT2AMEN1ELANEDDB1CRBN
SCHEMBL34474111 0.76 KMT2A (0.52) KMT2AMEN1ELANEDDB1CRBN
SCHEMBL835093 0.75 KMT2A (0.64) KMT2AMEN1DDB1CRBNL3MBTL1
SCHEMBL13201415 0.75 KMT2A (0.55) KMT2AMEN1ELANEDDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117377674-A Pyrazolo [1,5-a ] pyrimidine compounds for the treatment of dermatological disorders 大塚制药株式会社 2024-01-09 CN disclosed